Sangamo Biosciences reported $77M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amgen AMGN:US $ 4.33B 1.37B
Avrobio Inc AVRO:US 32.62M 1.24M
Bayer BAYN:GR 9.25B 3.88B
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Biogen BIIB:US $ 1984.9M 304.4M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Gilead Sciences GILD:US $ 3579M 392M
GlaxoSmithKline GSK:LN 7.14B 722M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Merk MRK:US $ 8328M 1460M
Novartis NOVN:VX 10.13B 319M
Omeros OMER:US $ 48.26M 4.58M
Pfizer PFE:US $ 16447M 3384M
Regulus Therapeutics RGLS:US $ 8.42M 1.78M
Sangamo Biosciences SGMO:US $ 77M 427K
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M
Ziopharm Oncology ZIOP:US $ 22.69M 55K